Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative imatinib in mesenchymal-type resectable colon cancer
NL-OMON47074Phase 2Active, not recruiting
- Sponsor
- Oncologie
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of imatinib in colon cancer, sponsored by Oncologie. Started May 2016; status: active, not recruiting.
02
Drugs
03
Conditions
colon cancer
Beyond the preview
Go deeper on NL-OMON47074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47074.